See the DrugPatentWatch profile for semaglutide
Common Side Effects and Their Typical Duration
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy, most often causes gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain. These typically start within the first few days to weeks of treatment and improve as the body adjusts.[1][2]
- Nausea often peaks in the first 4-8 weeks and resolves or lessens significantly for most people by 8-12 weeks.[1][3]
- Diarrhea and vomiting usually subside within 1-4 weeks.[2]
- Other GI effects like bloating or indigestion may linger up to 12 weeks but tend to fade with continued use.[3]
Dose escalation—starting low and increasing gradually every 4 weeks—helps minimize and shorten these effects.[1]
Factors Affecting Improvement Time
Improvement speed varies by individual factors:
- Dose and titration schedule: Faster ramps (e.g., weekly increases) can prolong symptoms; slower ones shorten them.[2]
- Patient specifics: Older adults, those with GI history, or higher starting doses see slower resolution, sometimes 12+ weeks.[3]
- Lifestyle: Eating smaller meals, avoiding fatty foods, and staying hydrated speeds relief.[1]
If side effects persist beyond 12 weeks or worsen, they rarely improve without dose adjustment or discontinuation.[2]
When Side Effects Don't Improve
About 5-10% of users experience persistent GI issues lasting months, leading to 10-20% discontinuation rates in trials.[3] Rare but serious effects like pancreatitis or gallbladder issues don't "improve" on their own and require immediate medical attention.[1] Thyroid tumors or vision changes (in animal studies) have no set resolution timeline and warrant stopping the drug.[2]
Tips to Speed Up Improvement
- Follow the prescribed slow titration.
- Use over-the-counter anti-nausea meds like ginger or ondansetron short-term, with doctor approval.
- Track symptoms daily; consult a provider if no progress after 4 weeks.[1]
Patients report 70-80% tolerance by month 3 in real-world use.[3]
Sources
[1] Ozempic.com Side Effects
[2] FDA Ozempic Label (2023)
[3] NEJM Semaglutide Trial Data (STEP 1)